IMMUPHARMA (LSE:IMM)

48.000
Today's low: 48.450
Sell IMM
51.000
Today's high: 48.450
Buy IMM
Last trade:
48.450
Change:
 -1.050 (-2.12%)
Volume:
1,112
Delayed price:
14:37:48
SETSqx
GBX

News

Latest News

Immupharma shareholders approve AGM resolutions

ImmuPharma (LON:IMM) the specialist drug discovery and development company, held its AGM earlier today and all resolutions were duly passed. At 1:14pm: (LON:IMM) ImmuPharma PLC share price was +1.25p at 50.5p

Result of AGM

RNS Number : 7744K Immupharma PLC 27 June 2014 FOR IMMEDIATE RELEASE 27 JUNE 2014 ANNUAL GENERAL MEETING: 2014 ImmuPharma PLC (LSE:IMM), (ImmuPharma or the Company), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed. A summary of proxy votes is shown in the table below. Please also refer to the Notice of Meeting in the Report Accounts - 31 ...

ImmuPharma extends research capabilities

ImmuPharma has extended its research capabilities by setting up its own research team within the nstitut Europen de Chimie et Biologie in Bordeaux. IECB is an international and interdisciplinary research team incubator, placed under the joint authority of the Centre National de la Recherche Scientifique, INSERM (Institut National de la Sant et de la Recherche Mdicale) and the University of Bordeaux. Through its network, IECB hosts 15 ...

All News

DateHeadlineSource
27-06-2014Immupharma shareholders approve AGM resolutionsStockMarketWire
27-06-2014Result of AGMRNS
27-06-2014ImmuPharma extends research capabilitiesStockMarketWire
27-06-2014Access to pioneering research in Bordeaux FranceRNS
16-06-2014ImmuPharma granted new Nucant patents StockMarketWire
16-06-2014NEW NUCANT PATENTSRNS
23-05-2014Annual Financial ReportRNS
21-05-2014ImmuPharma pre-tax losses riseStockMarketWire
21-05-2014Preliminary ResultsRNS
06-05-2014ImmuPharma gives summary from lupus conference StockMarketWire
06-05-2014Dr. Sylviane Muller - Presentation AbstractRNS
23-04-2014Lupuzor founder presents at Osaka UniversityStockMarketWire
23-04-2014Dr. S Muller, founder of Lupuzor presentation.RNS
11-04-2014ImmuPharma Sponsors the 2014 European Lupus ConferRNS
14-10-2013Additional ListingRNS
27-09-2013ImmuPharma trims operating lossStockMarketWire
27-09-2013Half Yearly ReportRNS
13-08-2013ImmuPharma gives update on cancer programmeStockMarketWire
13-08-2013UPDATE CANCER PROGRAMME IPP-204106RNS
31-07-2013FDA GRANTS IMMUPHARMA AMENDED SPARNS
08-07-2013ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-2013ImmuPharma appoints opinion leaders to advisory board StockMarketWire
08-07-2013IMMUPHARMA APPOINTS WORLDWIDE KEY OPINION LEADERSRNS
05-06-2013Holding(s) in CompanyRNS
23-05-2013Result of AGMRNS
21-05-2013ImmuPharma agrees £50 financingStockMarketWire
21-05-2013?50M Financing Facility - Darwin StrategicRNS
22-04-2013Posting of Annual Report and AGM NoticeRNS
09-04-2013ImmuPharma losses riseStockMarketWire
09-04-2013Preliminary ResultsRNS
28-02-2013ImmuPharma starts trading on Stuttgart ExchangeStockMarketWire
28-02-2013ImmuPharma Commences Trading on Stuttgart ExchangeRNS
28-01-2013Director Deals - ImmuPharma PLC (IMM)StockMarketWire
28-01-2013Director/PDMR Shareholding - ReplacementRNS
28-01-2013Director Deals - ImmuPharma PLC (IMM)StockMarketWire
28-01-2013Director/PDMR ShareholdingRNS
28-01-2013CNRS confirms Lupuzor's effectivenessStockMarketWire
28-01-2013CNRS Confirms Lupuzor's (TM) EffectivenessRNS
15-11-2012Lupuzor PresentationRNS
05-11-2012Lupuzor PresentationRNS

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory